Cargando…
Pharmacogenomics, human genetic diversity and the incorporation and rejection of color/race in Brazil
Public funding for research on the action of drugs in countries like the United States requires that racial classification of research subjects should be considered when defining the composition of the samples as well as in data analysis, sometimes resulting in interpretations that Whites and Blacks...
Autores principales: | Santos, Ricardo Ventura, da Silva, Gláucia Oliveira, Gibbon, Sahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538779/ https://www.ncbi.nlm.nih.gov/pubmed/26290677 http://dx.doi.org/10.1057/biosoc.2014.21 |
Ejemplares similares
-
Inclusion and exclusion in the globalisation of genomics; the case of rare genetic disease in Brazil
por: Gibbon, Sahra, et al.
Publicado: (2018) -
Between personal and relational privacy: understanding the work of informed consent in cancer genetics in Brazil
por: Goldim, José Roberto, et al.
Publicado: (2015) -
Entangled local biologies: genetic risk, bodies and inequities in Brazilian cancer genetics
por: Gibbon, Sahra
Publicado: (2017) -
Translating Population Difference: The Use and Re-Use of Genetic Ancestry in Brazilian Cancer Genetics
por: Gibbon, Sahra
Publicado: (2016) -
Family medicine, ‘La Herencia’ and breast cancer; understanding the (dis)continuities of predictive genetics in Cuba
por: Gibbon, Sahra
Publicado: (2011)